Evidence map›Paper›PMID 35296808›Full record

ArticleMolecular psychiatry2022

Epigenetic repression of Wnt receptors in AD: a role for Sirtuin2-induced H4K16ac deacetylation of Frizzled1 and Frizzled7 promoters.

Ernest Palomer, Núria Martín-Flores, Sarah Jolly, Patricia Pascual-Vargas, Stefano Benvegnù, Marina Podpolny, Samuel Teo, Kadi Vaher, Takashi Saito, Takaomi C Saido and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. CSF proteome-wide study of neuropsychiatric symptoms of dementia.medRxiv : the preprint server for health sciences · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Frizzled receptors: gatekeepers of Wnt signaling in development and disease.Frontiers in cell and developmental biology · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. The sirtuin family in health and disease.Signal transduction and targeted therapy · 2022
    Review
  20. Osteoarthritis Pain.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Ernest PalomerDepartment of Cell and Developmental Biology, University College London, London, UK.ORCID http://orcid.org/0000-0001-8629-2443
Núria Martín-FloresDepartment of Cell and Developmental Biology, University College London, London, UK.
Sarah JollyARUK-UCL Drug Discovery Institute, University College London, London, UK.
Patricia Pascual-VargasDepartment of Cell and Developmental Biology, University College London, London, UK.
Stefano BenvegnùARUK-UCL Drug Discovery Institute, University College London, London, UK.
Marina PodpolnyDepartment of Cell and Developmental Biology, University College London, London, UK.
Samuel TeoDepartment of Cell and Developmental Biology, University College London, London, UK.
Kadi VaherDepartment of Cell and Developmental Biology, University College London, London, UK.ORCID http://orcid.org/0000-0002-0733-2505
Takashi SaitoDepartment of Neurocognitive Science, Institute of Brain Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Takaomi C SaidoLaboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako Saitama, Japan.ORCID http://orcid.org/0000-0003-1970-6903
Paul WhitingARUK-UCL Drug Discovery Institute, University College London, London, UK.
Patricia C SalinasDepartment of Cell and Developmental Biology, University College London, London, UK. p.salinas@ucl.ac.uk.ORCID http://orcid.org/0000-0002-5748-083X
University College London · GBAlzheimer’s Research UK · GBMRC Laboratory for Molecular Cell Biology · GBNagoya City University · JPRIKEN Center for Brain Science · JPUK Dementia Research Institute · GB

Funding

Medical Research Council MR/M024083/1
6 · The paper itself

Abstract

Growing evidence supports a role for deficient Wnt signalling in Alzheimer's disease (AD). First, the Wnt antagonist DKK1 is elevated in AD brains and is required for amyloid-β-induced synapse loss. Second, LRP6 Wnt co-receptor is required for synapse integrity and three variants of this receptor are linked to late-onset AD. However, the expression/role of other Wnt signalling components remain poorly explored in AD. Wnt receptors Frizzled1 (Fzd1), Fzd5, Fzd7 and Fzd9 are of interest due to their role in synapse formation/plasticity. Our analyses showed reduced FZD1 and FZD7 mRNA levels in the hippocampus of human early AD stages and in the hAPP

Indexed as

Alzheimer DiseaseReceptors, WntAnimalsEpigenetic RepressionFrizzled ReceptorsHumansMiceRNA, MessengerSirtuin 1Sirtuin 2Wnt Signaling PathwayFrizzled ReceptorsFZD1 protein, humanFzd1 protein, mouseFZD7 protein, humanFzd7 protein, mouseReceptors, WntRNA, MessengerSIRT1 protein, humanSirt2 protein, mouseSirtuin 1Sirtuin 2

Identifiers

PMID35296808
PMCPMC9205772
OpenAlexW4220974342

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.